Stent thrombosis in randomized clinical trials of drug-eluting stents.

By L. Mauri, Wen-hua Hsieh, J. Massaro, K. Ho, Ralph B. D’Agostino, D. Cutlip. New England Journal of Medicine, 2007

1,511 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. (2008, methodology): “The Academic Research Consortium definitions were used for stent thrombosis (definite, probable, possible).(25) Subacute stent thrombosis was defined as stent thrombosis occurring after discharge to 30 day follow-up, and late-stent thrombosis was defined as stent thrombosis occurring between 30 day ”
Coronary stents: current status. (2010, neutral): “(25) included patients who were reated for essentially stable de novo lesions, which had a ean lesion length of 23 to 24 mm, a mean vessel diameter f 2.”